Longevity health claims, checked against the evidence
Plain-English checks of anti-aging drugs, peptides, supplements, tests and treatments—without turning early science into a promise.
Simple answer
Many longevity health claims start with real biology, then overstate what has been proved in people. Use these checks to separate a plausible mechanism or biomarker from evidence of meaningful human benefit, while keeping risk and approval status visible.
This index covers health and anti-aging claims—not unverified claims about people living to extreme ages.
Start with popular longevity health claims
Open a direct evidence check, or use the filters below to compare evidence strength, risk and regulatory status.
No strong human evidence shows that BPC-157 heals tendon or ligament injuries. Most support is animal, cell or mechanism-based, and internet recovery claims should not be treated as proven clinical benefit.
TB-500 injury-recovery claims are not supported by strong human clinical evidence. The claim often relies on extrapolation from thymosin beta-4 biology and should be treated as unproven.
NMN may affect NAD-related biomarkers in some studies, but that does not prove it slows human aging. The stronger claim needs clinical outcomes, not only a molecule-level signal.
Evidence:Human trial evidenceRisk:Moderate riskStatus:Supplement status
There is no simple evidence-based winner between NR and NMN for longevity. Comparisons depend on dose form, endpoints, product quality and whether the outcome is a biomarker or a health result.
Evidence:Human trial evidenceRisk:Moderate riskStatus:Supplement status
NAD IV anti-aging claims are not supported by strong evidence. Infusion marketing often uses cellular language that does not prove meaningful aging outcomes.